4.7 Article

A semiautomatic CT-based ensemble segmentation of lung tumors: Comparison with oncologists' delineations and with the surgical specimen

期刊

RADIOTHERAPY AND ONCOLOGY
卷 105, 期 2, 页码 167-173

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2012.09.023

关键词

CT; Auto-segmentation; Inter-observer variability; NSCLC delineation

资金

  1. Dutch Cancer Society [KWF UM-2010-4776]
  2. National Institutes of Health [NIH-USA U01 CA 143062-01]
  3. Definiens AG
  4. QuIC-ConCePT project
  5. EFPIA
  6. Innovative Medicine Initiative Joint Undertaking (IMI JU) [115151]

向作者/读者索取更多资源

Purpose: To assess the clinical relevance of a semiautomatic CT-based ensemble segmentation method, by comparing it to pathology and to CT/PET manual delineations by five independent radiation oncologists in non-small cell lung cancer (NSCLC). Materials and methods: For 20 NSCLC patients (stages Ib-IIIb) the primary tumor was delineated manually on CT/PET scans by five independent radiation oncologists and segmented using a CT based semi-automatic tool. Tumor volume and overlap fractions between manual and semiautomatic-segmented volumes were compared. All measurements were correlated with the maximal diameter on macroscopic examination of the surgical specimen. Imaging data are available on www.cancerdata.org. Results: High overlap fractions were observed between the semi-automatically segmented volumes and the intersection (92.5 +/- 9.0, mean +/- SD) and union (94.2 +/- 6.8) of the manual delineations. No statistically significant differences in tumor volume were observed between the semiautomatic segmentation (71.4 +/- 83.2 cm(3), mean +/- SD) and manual delineations (81.9 +/- 94.1 cm(3); p = 0.57). The maximal tumor diameter of the semiautomatic-segmented tumor correlated strongly with the macroscopic diameter of the primary tumor (r = 0.96). Conclusions: Semiautomatic segmentation of the primary tumor on CT demonstrated high agreement with CT/PET manual delineations and strongly correlated with the macroscopic diameter considered as the gold standard. This method may be used routinely in clinical practice and could be employed as a starting point for treatment planning, target definition in multi-center clinical trials or for high throughput data mining research. This method is particularly suitable for peripherally located tumors. (C) 2012 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 105 (2012) 167-173

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Radiology, Nuclear Medicine & Medical Imaging

Technical note: A knowledge graph approach to registering tumour specific data of patient-candidates for proton therapy in the Netherlands

Petros Kalendralis, Matthijs Sloep, Ananya Choudhury, Lerau Seyben, Jasper Snel, Nibin Moni George, Joeri Veugen, Martijn Veening, Johannes A. Langendijk, Andre Dekker, Johan van Soest, Rianne Fijten

Summary: This study provides an overview of the tumour group data lists in the Dutch national proton therapy registry, and presents a knowledge graph approach using ontologies and semantic web technologies to describe head and neck tumour variables. The goal is to offer a flexible and interoperable data model for data exchange in the radiotherapy community, highlighting variables needed for the model-based approach.

MEDICAL PHYSICS (2023)

Article Chemistry, Analytical

Frequency-Domain-Based Structure Losses for CycleGAN-Based Cone-Beam Computed Tomography Translation

Suraj Pai, Ibrahim Hadzic, Chinmay Rao, Ivan Zhovannik, Andre Dekker, Alberto Traverso, Stylianos Asteriadis, Enrique Hortal

Summary: Research on CycleGAN-based synthetic image generation in the medical community has increased due to its effective utilization of unpaired images. However, the presence of artifacts in the generated images limits its reliability for medical imaging purposes. To overcome this, a generalized frequency-based loss is proposed to preserve frequency content. The proposed methods outperform the baseline CycleGAN and existing techniques, exhibiting quantitatively and qualitatively improved results without introducing artifacts or loss in image quality. Furthermore, the generated sCTs demonstrate superior performance compared to original CBCT images in downstream tasks.

SENSORS (2023)

Article Oncology

Growth in eligibility criteria content and failure to accrue among National Cancer Institute (NCI)-affiliated clinical trials

John S. Peterson, Deborah Plana, Danielle S. Bitterman, Skyler Bryce Johnson, Hugo J. W. L. Aerts, Benjamin Harris Kann

Summary: The study found that the content of eligibility criteria in NCI-affiliated trials is growing rapidly and is strongly associated with accrual failure. These findings support initiatives to simplify eligibility criteria and suggest that further efforts are needed to improve cancer trial accrual.

CANCER MEDICINE (2023)

Article Oncology

Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes

Audrey R. Freischel, Jamie K. Teer, Kimberly Luddy, Jessica Cunningham, Yael Artzy-Randrup, Tamir Epstein, Kenneth Y. Tsai, Anders Berglund, John L. Cleveland, Robert J. Gillies, Joel S. Brown, Robert A. Gatenby

Summary: Evolution plays a crucial role in the initiation and progression of cancer. In addition to driver mutations, natural selection conserves genes that are necessary for optimal cancer cell fitness. By studying subtypes of lung adenocarcinoma, we identified highly mutated and highly conserved genes, which have common utility in adapting to similar tissue environments and are critical for optimal fitness. Targeting tumor-specific conserved genes may represent an effective treatment strategy.

CANCERS (2023)

Article Computer Science, Interdisciplinary Applications

Dual center validation of deep learning for automated multi-label segmentation of thoracic anatomy in bedside chest radiographs

Felix Busch, Lina Xu, Dmitry Sushko, Matthias Weidlich, Daniel Truhn, Gustav Mueller-Franzes, Maurice M. Heimer, Stefan M. Niehues, Marcus R. Makowski, Markus Hinsche, Janis L. Vahldiek, Hugo J. W. L. Aerts, Lisa C. Adams, Keno K. Bressem

Summary: This study aims to develop an efficient convolutional neural network for automatic anatomy segmentation of bedside chest radiographs (CXRs). By using a human-in-the-loop segmentation workflow with an active learning approach, the performance of artificial intelligence in diagnosing cardiothoracic disease and invasive therapy devices is improved. The final model achieved comparable performance to state-of-the-art approaches.

COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2023)

Article Oncology

Computed tomography-based radiomics for the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer patients treated with immune checkpoint inhibitors

Fariba Tohidinezhad, Dennis Bontempi, Zhen Zhang, Anne-Marie Dingemans, Joachim Aerts, Gerben Bootsma, Johan Vansteenkiste, Sayed Hashemi, Egbert Smit, Hester Gietema, Hugo J. W. L. Aerts, Andre Dekker, Lizza E. L. Hendriks, Alberto Traverso, Dirk De Ruysscher

Summary: This study aimed to develop a prediction model to differentiate immunotherapy-induced pneumonitis (IIP) from other types of pneumonitis (OTP) in non-small cell lung cancer patients. The radiomic biomarkers applied to computed tomography imaging can assist clinicians in making a diagnosis when the radiological assessment is inconclusive.

EUROPEAN JOURNAL OF CANCER (2023)

Article Health Care Sciences & Services

What Does DALL-E 2 Know About Radiology?

Lisa C. Adams, Felix Busch, Daniel Truhn, Marcus R. Makowski, Hugo J. W. L. Aerts, Keno K. Bressem

Summary: DALL-E 2 shows promising capabilities in generating and manipulating x-ray images, but has limitations in generating images with pathological abnormalities or other medical imaging modalities.

JOURNAL OF MEDICAL INTERNET RESEARCH (2023)

Article Multidisciplinary Sciences

Antibodies against endogenous retroviruses promote lung cancer immunotherapy

Kevin Ng, Jesse Boumelha, Katey S. S. Enfield, Jorge L. Almagro, Hongui M. Cha, Oriol Pich, Takahiro Karasaki, David Moore, Roberto Salgado, Monica Sivakumar, George Young, Miriam L. Molina-Arcas, Sophie de Carne Trecesson, Panayiotis Anastasiou, Annika C. Fendler, Lewis Au, Scott T. C. Shepherd, Carlos Martinez-Ruiz, Clare Puttick, James R. M. Black, Thomas B. K. Watkins, Hyemin Kim, Seohee Shim, Nikhil Faulkner, Jan A. Attig, Selvaraju Veeriah, Neil J. Magno, Sophia T. Ward, Alexander Frankell, Maise Al Bakir, Emilia Lim, Mark Hill, Gareth Wilson, Daniel Cook, Nicolai Birkbak, Axel Behrens, Nadia Yousaf, Sanjay Popat, Allan Hackshaw, TRACERx Consortium, CAPTURE Consortium, Crispin T. Hiley, Kevin Litchfield, Nicholas McGranahan, Mariam Jamal-Hanjani, James Larkin, Se-Hoon Lee, Samra Turajlic, Charles Swanton, Julian Downward, George Kassiotis

Summary: This study reveals that lung adenocarcinomas in both humans and mice elicit local germinal center responses and tumour-binding antibodies, with endogenous retrovirus (ERV) envelope glycoproteins as the dominant anti-tumour antibody target. ERV-targeting B cell responses are enhanced by immune checkpoint blockade (ICB) and targeted inhibition of KRAS(G12C). ERV-reactive antibodies have anti-tumour activity and improve survival in a mouse model, and ERV expression predicts the response to ICB in human lung adenocarcinoma. Furthermore, the study demonstrates that effective immunotherapy in the mouse model requires CXCL13-dependent tertiary lymphoid structure (TLS) formation, and therapeutic CXCL13 treatment enhances anti-tumour immunity and synergizes with ICB. These findings provide a potential mechanistic basis for the association between TLS and immunotherapy response.

NATURE (2023)

Article Multidisciplinary Sciences

The evolution of non-small cell lung cancer metastases in TRACERx

Maise Al Bakir, Ariana Huebner, Carlos Martinez-Ruiz, Kristiana Grigoriadis, Thomas B. K. Watkins, Oriol Pich, David A. Moore, Selvaraju Veeriah, Sophia Ward, Joanne Laycock, Diana Johnson, Andrew Rowan, Maryam Razaq, Mita Akther, Cristina Naceur-Lombardelli, Paulina Prymas, Antonia Toncheva, Sonya Hessey, Michelle Dietzen, Emma Colliver, Alexander Frankell, Abigail Bunkum, Emilia L. Lim, Takahiro Karasaki, Christopher Abbosh, Crispin T. Hiley, Mark S. Hill, Daniel E. Cook, Gareth A. Wilson, Roberto Salgado, Emma Nye, Richard Kevin Stone, Dean A. Fennell, Gillian Price, Keith M. Kerr, Babu Naidu, Gary Middleton, Yvonne Summers, Colin R. Lindsay, Fiona H. Blackhall, Judith Cave, Kevin G. Blyth, Arjun Nair, Asia Ahmed, Magali N. Taylor, Alexander James Procter, Mary Falzon, David Lawrence, Neal Navani, Ricky M. Thakrar, Sam M. Janes, Dionysis Papadatos-Pastos, Martin D. Forster, Siow Ming Lee, Tanya Ahmad, Sergio Quezada, Karl S. Peggs, Peter Van Loo, Caroline Dive, Allan Hackshaw, Nicolai J. Birkbak, Simone Zaccaria, Mariam Jamal-Hanjani, Nicholas McGranahan, Charles Swanton, Jason F. Lester, Amrita Bajaj, Apostolos Nakas, Azmina Sodha-Ramdeen, Keng Ang, Mohamad Tufail, Mohammed Fiyaz Chowdhry, Molly Scotland, Rebecca Boyles, Sridhar Rathinam, Claire Wilson, Domenic Marrone, Sean Dulloo, Gurdeep Matharu, Jacqui A. Shaw, Joan Riley, Lindsay Primrose, Ekaterini Boleti, Heather Cheyne, Mohammed Khalil, Shirley Richardson, Tracey Cruickshank, Sarah Benafif, Kayleigh Gilbert, Akshay J. Patel, Aya Osman, Christer Lacson, Gerald Langman, Helen Shackleford, Madava Djearaman, Salma Kadiri, Angela Leek, Jack Davies Hodgkinson, Nicola Totten, Angeles Montero, Elaine Smith, Eustace Fontaine, Felice Granato, Helen Doran, Juliette Novasio, Kendadai Rammohan, Leena Joseph, Paul Bishop, Rajesh Shah, Stuart Moss, Vijay Joshi, Philip Crosbie, Fabio Gomes, Kate Brown, Mathew Carter, Anshuman Chaturvedi, Lynsey Priest, Pedro Oliveira, Matthew G. Krebs, Alexandra Clipson, Jonathan Tugwood, Alastair Kerr, Dominic G. Rothwell, Elaine Kilgour, Hugo J. W. L. Aerts, Roland F. Schwarz, Tom L. Kaufmann, Rachel Rosenthal, Zoltan Szallasi, Judit Kisistok, Mateo Sokac, Miklos Diossy, Jonas Demeulemeester, Aengus Stewart, Alastair Magness, Angeliki Karamani, Benny Chain, Brittany B. Campbell, Carla Castignani, Chris Bailey, Clare Puttick, Clare E. Weeden, Claudia Lee, Corentin Richard, David R. Pearce, Despoina Karagianni, Dhruva Biswas, Dina Levi, Elena Hoxha, Elizabeth Larose Cadieux, Eva Gronroos, Felip Galvez-Cancino, Foteini Athanasopoulou, Francisco Gimeno-Valiente, George Kassiotis, Georgia Stavrou, Gerasimos Mastrokalos, Haoran Zhai, Helen L. Lowe, Ignacio Matos, Jacki Goldman, James L. Reading, James R. M. Black, Javier Herrero, Jayant K. Rane, Jerome Nicod, Jie Min Lam, John A. Hartley, Katey S. S. Enfield, Kayalvizhi Selvaraju, Kerstin Thol, Kevin Litchfield, Kevin W. Ng, Kezhong Chen, Krijn Dijkstra, Krupa Thakkar, Leah Ensell, Mansi Shah, Marcos Vasquez, Maria Litovchenko, Mariana Werner Sunderland, Michelle Leung, Mickael Escudero, Mihaela Angelova, Miljana Tanic, Monica Sivakumar, Nnennaya Kanu, Olga Chervova, Olivia Lucas, Othman Al-Sawaf, Philip Hobson, Piotr Pawlik, Robert Bentham, Robert E. Hynds, Roberto Vendramin, Sadegh Saghafinia, Saioa Lopez, Samuel Gamble, Seng Kuong Anakin Ung, Sharon Vanloo, Stefan Boeing, Stephan Beck, Supreet Kaur Bola, Tamara Denner, Teresa Marafioti, Thanos P. Mourikis, Victoria Spanswick, Vittorio Barbe, Wei-Ting Lu, William Hill, Wing Kin Liu, Yin Wu, Yutaka Naito, Zoe Ramsden, Catarina Veiga, Gary Royle, Charles-Antoine Collins-Fekete, Francesco Fraioli, Paul Ashford, Tristan Clark, Elaine Borg, James Wilson, Davide Patrini, Emilie Martinoni Hoogenboom, Fleur Monk, James W. Holding, Junaid Choudhary, Kunal Bhakhri, Marco Scarci, Martin Hayward, Nikolaos Panagiotopoulos, Pat Gorman, Reena Khiroya, Robert C. M. Stephens, Yien Ning Sophia Wong, Steve Bandula, Abigail Sharp, Sean Smith, Nicole Gower, Harjot Kaur Dhanda, Kitty Chan, Camilla Pilotti, Rachel Leslie, Anca Grapa, Hanyun Zhang, Khalid AbdulJabbar, Xiaoxi Pan, Yinyin Yuan, David Chuter, Mairead MacKenzie, Serena Chee, Aiman Alzetani, Lydia Scarlett, Jennifer Richards, Papawadee Ingram, Silvia Austin, Eric Lim, Paulo De Sousa, Simon Jordan, Alexandra Rice, Hilgardt Raubenheimer, Harshil Bhayani, Lyn Ambrose, Anand Devaraj, Hema Chavan, Sofina Begum, Silviu Buderi, Daniel Kaniu, Mpho Malima, Sarah Booth, Andrew G. Nicholson, Nadia Fernandes, Pratibha Shah, Chiara Proli, Madeleine Hewish, Sarah Danson, Michael J. Shackcloth, Lily Robinson, Peter Russell, Craig Dick, John Le Quesne, Alan Kirk, Mo Asif, Rocco Bilancia, Nikos Kostoulas, Mathew Thomas

Summary: Through longitudinal evolutionary analysis of 126 non-small cell lung cancer tumors, it was found that 25% of cases showed early metastatic divergence before the last clonal sweep in the primary tumor, which was enriched in patients who were smokers at the time of initial diagnosis. Polyclonal dissemination was associated with tumor recurrence, while primary lymph node disease played a limited role in metastatic relapse. Our study highlights the importance of selection in metastatic clone evolution within untreated primary tumors.

NATURE (2023)

Article Oncology

Computed tomography and radiation dose images-based deep-learning model for predicting radiation pneumonitis in lung cancer patients after radiation therapy

Zhen Zhang, Zhixiang Wang, Tianchen Luo, Meng Yan, Andre Dekker, Dirk De Ruysscher, Alberto Traverso, Leonard Wee, Lujun Zhao

Summary: The purpose of this study is to develop a deep learning model that combines CT and radiation dose (RD) images to predict the occurrence of radiation pneumonitis (RP) in lung cancer patients who received radical (chemo)radiotherapy. CT, RD images, and clinical parameters were obtained from a training set of 314 retrospectively-collected patients and a test set of 35 prospectively-collected patients. External validation was conducted using patients from a clinical trial. The results showed that the deep learning approach effectively and accurately predicted the occurrence of RP.

RADIOTHERAPY AND ONCOLOGY (2023)

Article Oncology

pCR and 2-Year Disease-Free Survival: A Combination of the Two Endpoints as a New Classification for Locally Advanced Rectal Cancer Patients-An Updated Pooled Analysis of Eleven International Randomized Trials

Maria Antonietta Gambacorta, Giuditta Chiloiro, Carlotta Masciocchi, Silvia Mariani, Angela Romano, Alessandra Gonnelli, Jean-Pierre Gerard, Samuel Ngan, Claus Roedel, Krzysztof Bujko, Robert Glynne-Jones, Johan van Soest, Andre Dekker, Andrea Damiani, Vincenzo Valentini

Summary: This study conducted a pooled analysis on a large cohort of rectal cancer patients to assess the role of pCR and 2yDFS as surrogate endpoints for OS. The results contribute to understanding the prognostic role of these two endpoints and can help identify high-risk patients for personalized treatments.

CANCERS (2023)

Article Medical Informatics

Screening for extranodal extension in HPV-associated oropharyngeal carcinoma: evaluation of a CT-based deep learning algorithm in patient data from a multicentre, randomised de-escalation trial

Benjamin H. Kann, Jirapat Likitlersuang, Dennis Bontempi, Zezhong Ye, Sanjay Aneja, Richard Bakst, Hillary R. Kelly, Amy F. Juliano, Sam Payabvash, Jeffrey P. Guenette, Ravindra Uppaluri, Danielle N. Margalit, Jonathan D. Schoenfeld, Roy B. Tishler, Robert Haddad, Hugo J. W. L. Aerts, Joaquin J. Garcia, Yael Flamand, Rathan M. Subramaniam, Barbara A. Burtness, Robert L. Ferris

Summary: This study evaluated a CT-based deep learning algorithm for predicting pathological extranodal extension (ENE) in patients with HPV-associated oropharyngeal carcinoma. The algorithm showed better performance than four board-certified head and neck radiologists in classifying ENE, suggesting its potential as a treatment selection tool.

LANCET DIGITAL HEALTH (2023)

Article Food Science & Technology

Applying federated learning to combat food fraud in food supply chains

Anand Gavai, Yamine Bouzembrak, Wenjuan Mu, Frank Martin, Rajaram Kaliyaperumal, Johan van Soest, Ananya Choudhury, Jaap Heringa, Andre Dekker, Hans J. P. Marvin

Summary: Artificial Intelligence (AI) based algorithms, particularly data driven Bayesian Network (BN) models, are suitable for predicting future food fraud and enabling timely actions by food producers. However, data sharing is hindered due to various concerns, such as interests, security, and privacy. Federated learning (FL) technology can address these issues, allowing integration of data from different sources while ensuring data privacy and confidentiality. This research demonstrates the potential of FL for food fraud control and decision-making in the food supply chain.

NPJ SCIENCE OF FOOD (2023)

Article Microbiology

Development of a CRISPR-Cas12a system for efficient genome engineering in clostridia

Yanchao Zhang, Aleksandra M. Kubiak, Tom S. Bailey, Luuk Claessen, Philip Hittmeyer, Ludwig Dubois, Jan Theys, Philippe Lambin

Summary: Clostridium species have gained attention in industrial and medical applications, with the development of genetic tools enabling the advancement of the CRISPR-Cas systems. This study demonstrated the establishment of a CRISPR-Cas12a system in clostridia with two different cas12a genes, allowing for efficient and rapid genome modification. The results showed that the CRISPR-FnCas12a system offers flexible target selection in clostridia, with a specific folding pattern of the precursor crRNA being important for high mutation generation efficiency.

MICROBIOLOGY SPECTRUM (2023)

Article Computer Science, Artificial Intelligence

medBERT.de: A comprehensive German BERT model for the medical domain

Keno K. Bressem, Jens-Michalis Papaioannou, Paul Grundmann, Florian Borchert, Lisa C. Adams, Leonhard Liu, Felix Busch, Lina Xu, Jan P. Loyen, Stefan M. Niehues, Moritz Augustin, Lennart Grosser, Marcus R. Makowski, Hugo J. W. L. Aerts, Alexander Loeser

Summary: This paper presents medBERT.de, a pre-trained German BERT model designed specifically for the German medical domain. The model achieves state-of-the-art performance on various medical benchmarks and the analysis investigates the impact of data deduplication and tokenization methods on the model's performance.

EXPERT SYSTEMS WITH APPLICATIONS (2024)

Article Oncology

Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group

Derek A. Mumaw, Allison J. Hazy, Aleksander Vayntraub, Thomas J. Quinn, Kamran Salari, John H. Chang, Noah Kalman, Sanford Katz, James Urbanic, Robert H. Press, Arpi Thukral, Henry Tsai, George E. Laramore, Jason Molitoris, Carlos Vargas, Samir H. Patel, Craig Stevens, Rohan L. Deraniyagala

Summary: This study evaluated contralateral recurrences in patients with oropharyngeal squamous cell carcinoma who received unilateral proton beam therapy. The results showed a favorable contralateral neck failure rate that was comparable to photon irradiation.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Outcomes following hypofractionated radiation therapy alone for surgically unfit early esophageal squamous cell carcinoma patients; a retrospective single center analysis

Kangpyo Kim, Dongryul Oh, Jae Myoung Noh, Yang Won Min, Hong Kwan Kim, Yong Chan Ahn

Summary: This study suggests that hypofractionated radiation therapy alone is a feasible option for early stage esophageal squamous cell carcinoma patients. Particularly, in patients with tumor length < 3 cm, this treatment scheme shows favorable local control rates with low incidence of esophageal toxicities.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy

Lin Chen, Jing Li, Kunpeng Li, Jiang Hu, Qingjie Li, Chenglong Huang, Gaoyuan Wang, Na Liu, Linglong Tang

Summary: This study analyzed the probability of hearing impairment after radiotherapy for nasopharyngeal carcinoma and developed a predictive model, providing dose limitation suggestions to improve patients' quality of life.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

FLASH radiotherapy using high-energy X-rays: Current status of PARTER platform in FLASH research

Yiwei Yang, Jianxin Wang, Feng Gao, Zhen Liu, Tangzhi Dai, Haowen Zhang, Hongyu Zhu, Tingting Wang, Dexin Xiao, Kui Zhou, Zheng Zhou, Dai Wu, Xiaobo Du, Sen Bai

Summary: This paper provides a comprehensive description of the current status of PARTER, which is the first experimental FLASH platform utilizing megavoltage X-rays. It showcases the reliable performance and stability of the dosimeters and monitors used in PARTER, as well as the satisfactory dose distribution and characteristics of the FLASH X-rays. The platform effectively meets the requirements of preclinical research on megavoltage X-ray FLASH and undergoes continuous upgrades.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation

Maria Thor, Kelly Fitzgerald, Aditya Apte, Jung Hun Oh, Aditi Iyer, Otasowie Odiase, Saad Nadeem, Ellen D. Yorke, Jamie Chaft, Abraham J. Wu, Michael Offin, Charles B. Simone Ii, Isabel Preeshagul, Daphna Y. Gelblum, Daniel Gomez, Joseph O. Deasy, Andreas Rimner

Summary: The purpose of this study was to identify predictors of disease progression in early-stage non-small cell lung cancer (NSCLC) patients after receiving definitive stereotactic body radiation therapy (SBRT). The results showed that tumor diameter and SUVmax were the most frequently reported features associated with progression/survival, and a re-fitted model including these two features had the best performance.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

A comprehensive predictive model for radiation-induced brain injury in risk stratification and personalized radiotherapy of nasopharyngeal carcinoma

Yong-Qiao He, Tong-Min Wang, Da-Wei Yang, Wen-Qiong Xue, Chang-Mi Deng, Dan-Hua Li, Wen-Li Zhang, Ying Liao, Ruo-Wen Xiao, Lu-Ting Luo, Hua Diao, Xia-Ting Tong, Yan-Xia Wu, Xue-Yin Chen, Jiang-Bo Zhang, Ting Zhou, Xi-Zhao Li, Pei-Fen Zhang, Xiao-Hui Zheng, Shao-Dan Zhang, Ye-Zhu Hu, Guan-Qun Zhou, Jun Ma, Ying Sun, Wei-Hua Jia

Summary: In this study, researchers aimed to establish a predictive model for radiation-induced brain injury (RBI) in nasopharyngeal carcinoma (NPC) patients by incorporating clinical factors and newly developed genetic variants. They conducted a large-scale retrospective study and a genome-wide association study to develop a polygenic risk score (PRS) for RBI risk prediction. The results showed that the PRS, combined with clinical factors, improved the accuracy of RBI risk stratification and suggested personalized radiotherapy.

RADIOTHERAPY AND ONCOLOGY (2024)

Review Oncology

Brachytherapy is an effective and safe salvage option for re-irradiation in recurrent glioblastoma (rGBM): A systematic review

Xiaoyong Xiang, Zhe Ji, Jing Jin

Summary: A review of studies suggests that brachytherapy as a salvage therapy for recurrent glioblastoma shows acceptable safety and good post-treatment clinical efficacy for selected patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts

M. Berbee, C. T. Muijs, F. E. M. Voncken, L. Wee, M. Sosef, B. van Etten, J. W. van Sandick, F. A. R. M. Warmerdam, J. J. de Haan, E. Oldehinkel, J. M. van Dieren, L. Boersma, J. A. Langendijk, A. van der Schaaf, J. B. Reitsma, E. Schuit

Summary: This study externally validated a model for predicting 2-year total mortality in lung cancer patients in esophageal cancer patients. The intercept and/or slope of the original model needed adjustment to achieve good performance in esophageal cancer patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Nine years of plan of the day for cervical cancer: Plan library remains effective compared to fully online-adaptive techniques

Dominique Reijtenbagh, Jeremy Godart, Joan Penninkhof, Sandra Quint, Andras Zolnay, Jan-Willem Mens, Mischa Hoogeman

Summary: This study compared the performance of the current PotD strategy with non-adaptive and fully online-adaptive techniques in the treatment of cervical cancer patients. The findings show that the PotD protocol is effective in improving normal tissue sparing compared to no adaptation, while fully online-adaptive approaches can further reduce target volume but come with a more complex workflow.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Prediction of radiation pneumonitis using the effective α/β of lungs and heart in NSCLC patients treated with proton beam therapy

Albrecht Weiss, Steffen Loeck, Ting Xu, Zhongxing Liao, Aswin L. Hoffmann, Esther G. C. Troost

Summary: Traditional models for predicting radiation pneumonitis may not be applicable to non-small cell lung cancer patients treated with passively-scattered proton therapy. The use of effective alpha/beta parameter can predict the occurrence of radiation pneumonitis in these patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Primer shot fractionation with an early treatment break is theoretically superior to consecutive weekday fractionation schemes for early-stage non-small cell lung cancer

Z. A. R. Gouw, J. Jeong, A. Rimner, N. Y. Lee, A. Jackson, A. Fu, J-j. Sonke, J. O. Deasy

Summary: This study investigates the effectiveness of non-uniform fractionation schedules in radiotherapy for early-stage non-small cell lung cancer. Through modeling, optimized schedules are proposed to minimize local failures and toxicity risk. The results suggest that non-standard primer shot fractionation can reduce hypoxia-induced radioresistance and improve treatment outcomes.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity

Sara Ronchi, Alessandro Cicchetti, Maria Bonora, Rossana Ingargiola, Anna Maria Camarda, Stefania Russo, Sara Imparato, Paolo Castelnuovo, Ernesto Pasquini, Piero Nicolai, Mohssen Ansarin, Michele Del Vecchio, Marco Benazzo, Ester Orlandi, Barbara Vischioni

Summary: This study evaluates the efficacy and toxicity of carbon ion radiotherapy (CIRT) in locally advanced head and neck mucosal melanoma patients. The results show that CIRT is safe and effective in treating the local region, and immunotherapy after relapse can improve overall survival. However, further prospective trials are needed to assess the role of targeted/immune- systemic therapy in this disease.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

The rise of negative portrayals of radiation oncology: A textual analysis of media news

Dominik Wawrzuta, Justyna Klejdysz, Marzanna Chojnacka

Summary: This study analyzed articles about radiation oncology published in The New York Times since its inception in 1851, and identified changes in media sentiment and prevalent themes related to radiotherapy. The findings suggest an increasing negative sentiment in media coverage towards radiotherapy, with a shift towards reporting treatment errors, toxicity, and ineffectiveness.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses

Elaine Limkin, Pierre Blanchard, Benjamin Lacas, Jean Bourhis, Mahesh Parmar, Lisa Licitra, Quynh-Thu Le, Sue S. Yom, Catherine Fortpied, Johannes Langendijk, Jan B. Vermorken, Jacques Bernier, Jens Overgaard, Jonathan Harris, Jean-Pierre Pignon, Anne Auperin

Summary: This study investigated the impact of season of radiotherapy on the outcomes of head and neck squamous cell cancer patients. The results showed that the season of radiotherapy did not have any significant effect on patient outcomes.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS)

Fabio L. Cury, Gustavo A. Viani, Andre G. Gouveia, Camila V. S. Freire, Gabriel de A. Grisi, Fabio Y. Moraes

Summary: In limb-sparing treatment of soft tissue sarcoma patients, a 5-day course of preoperative radiotherapy results in high local control and favorable R0 margins, with acceptable complication rates, particularly for patients receiving higher biological equivalent doses.

RADIOTHERAPY AND ONCOLOGY (2024)